All Stories

  1. Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition

    Article • RSC Advances, January 2025, Royal Society of Chemistry

    Paula Videira

  2. Decoding the Molecular Basis of the Specificity of an Anti-sTn Antibody

    Article • JACS Au, December 2024, American Chemical Society (ACS)

    Paula Videira

  3. New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells

    Article • Medical Oncology, November 2024, Springer Science + Business Media

    Paula Videira

  4. Mapping the diagnostic odyssey of congenital disorders of glycosylation (CDG): insights from the community

    Article • Orphanet Journal of Rare Diseases, November 2024, Springer Science + Business Media

    Paula Videira

  5. A community-centric model for conference co-creation: the world conference on CDG for patients, families and professionals

    Article • Research Involvement and Engagement, October 2024, Springer Science + Business Media

    Paula Videira

  6. The role of sialoglycans in modulating dendritic cell function and tumour immunity

    Article • Seminars in Immunology, July 2024, Elsevier

    Paula Videira

  7. Revisiting the immunopathology of congenital disorders of glycosylation: an updated review

    Article • Frontiers in Immunology, March 2024, Frontiers

    Paula Videira

  8. Cardiolipin Membranes Promote Cytochrome c Transformation of Polycyclic Aromatic Hydrocarbons and Their In Vivo Metabolites

    Article • Molecules, March 2024, MDPI AG

    Paula Videira

  9. New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells

    Article • February 2024, Springer Science + Business Media

    Paula Videira

  10. Advancing cancer immunotherapy: from innovative preclinical models to clinical insights

    Article • Scientific Reports, January 2024, Springer Science + Business Media

    Paula Videira

  11. Altered expression of Sialyl Lewis X in experimental models of Parkinson’s disease

    Article • Journal of Molecular Medicine, January 2024, Springer Science + Business Media

    Paula Videira

  12. Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes

    Article • Journal of Visualized Experiments, October 2023, MyJove Corporation

    Paula Videira

  13. Congenital disorders of glycosylation (CDG): state of the art in 2022

    Article • Orphanet Journal of Rare Diseases, October 2023, Springer Science + Business Media

    Paula Videira

  14. Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Paula Videira

  15. Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer

    Article • Cancers, January 2023, MDPI AG

    Paula Videira

  16. A Community-Based Participatory Framework to Co-Develop Patient Education Materials (PEMs) for Rare Diseases: A Model Transferable across Diseases

    Article • International Journal of Environmental Research and Public Health, January 2023, MDPI AG

    Maria Grazia Rossi, Paula Videira

  17. Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals

    Article • Orphanet Journal of Rare Diseases, October 2022, Springer Science + Business Media

    Paula Videira

  18. A Participatory Framework for Plain Language Clinical Management Guideline Development

    Article • International Journal of Environmental Research and Public Health, October 2022, MDPI AG

    Paula Videira

  19. Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)

    Article • International Journal of Molecular Sciences, August 2022, MDPI AG

    Paula Videira

  20. Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective

    Article • Orphanet Journal of Rare Diseases, July 2022, Springer Science + Business Media

    Paula Videira

  21. Concerted Regulation of Glycosylation Factors Sustains Tissue Identity and Function

    Article • Biomedicines, July 2022, MDPI AG

    Paula Videira

  22. Oxidative Stress and Inflammatory Response of Skin Fibroblasts Exposed to Chlorpyrifos

    Article • July 2022, MDPI AG

    Paula Videira

  23. Editorial: Biomarkers in Genitourinary Cancers, Volume I

    Article • Frontiers in Oncology, July 2022, Frontiers

    Paula Videira

  24. Targeting Immune-Mediated Responses to Tackle GNE Myopathy

    Article • July 2022, MDPI AG

    Paula Videira

  25. Registered human trials addressing environmental and occupational toxicant exposures: Scoping review of immunological markers and protective strategies

    Article • Environmental Toxicology and Pharmacology, July 2022, Elsevier

    Paula Videira

  26. Use of Lipid Vesicles for Revealing the Potential Contribution of Cytochrome C in the Metabolism of Environmental Toxicants

    Article • June 2022, MDPI AG

    Paula Videira

  27. A Community-Led Approach as a Guide to Overcome Challenges for Therapy Research in Congenital Disorders of Glycosylation

    Article • International Journal of Environmental Research and Public Health, June 2022, MDPI AG

    Paula Videira

  28. Comparison of Laccases and Hemeproteins Systems in Bioremediation of Organic Pollutants

    Article • Current Protein and Peptide Science, June 2022, Bentham Science Publishers

    Paula Videira

  29. The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ)

    Article • Orphanet Journal of Rare Diseases, March 2022, Springer Science + Business Media

    Paula Videira

  30. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy

    Article • Bioorganic & Medicinal Chemistry, January 2022, Elsevier

    Paula Videira

  31. Structural Insights in Mammalian Sialyltransferases and Fucosyltransferases: We Have Come a Long Way, but It Is Still a Long Way Down

    Article • Molecules, August 2021, MDPI AG

    Paula Videira

  32. Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer

    Article • Cancers, August 2021, MDPI AG

    Paula Videira, Cristina Casalou

  33. Artificial Intelligence in Epigenetic Studies: Shedding Light on Rare Diseases

    Article • Frontiers in Molecular Biosciences, May 2021, Frontiers

    Paula Videira

  34. Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis

    Article • Frontiers in Medicine, April 2021, Frontiers

    Paula Videira

  35. L1CAM as an E-selectin Ligand in Colon Cancer

    Article • International Journal of Molecular Sciences, November 2020, MDPI AG

    Paula Videira

  36. International consensus guidelines for phosphoglucomutase 1 deficiency ( PGM1‐CDG ): Diagnosis, follow‐up, and management

    Article • Journal of Inherited Metabolic Disease, September 2020, Wiley

    Rita Barone, Paula Videira

  37. New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach

    Article • Journal of Clinical Medicine, July 2020, MDPI AG

    Paula Videira

  38. Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers

    Article • Journal of Experimental & Clinical Cancer Research, May 2020, Springer Science + Business Media

    Paula Videira

  39. Functional and Physiological Methods of Evaluating Median Nerve Regeneration in the Rat

    Article • Journal of Visualized Experiments, April 2020, MyJove Corporation

    Paula Videira

  40. MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells

    Article • Pharmaceutics, March 2020, MDPI AG

    Paula Videira

  41. Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?

    Article • Genes, November 2019, MDPI AG

    Paula Videira

  42. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer

    Article • International Journal of Oncology, September 2019, Spandidos Publications

    Paula Videira

  43. CDG and immune response: From bedside to bench and back

    Article • Journal of Inherited Metabolic Disease, June 2019, Wiley

    Paula Videira

  44. BD-2 and BD-3 increase skin flap survival in a model of ischemia and Pseudomonas aeruginosa infection

    Article • Scientific Reports, May 2019, Springer Science + Business Media

    Paula Videira

  45. Unconventional Perfusion Flaps in the Experimental Setting

    Article • Plastic & Reconstructive Surgery, May 2019, Wolters Kluwer Health

    Diogo Casal, Paula Videira

  46. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up

    Article • Journal of Inherited Metabolic Disease, April 2019, Wiley

    Rita Barone, Paula Videira

  47. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications

    Article • New Biotechnology, March 2019, Elsevier

    Professor Luis Lima, Paula Videira

  48. Application of Hyperthermia for Cancer Treatment: Synthesis and Characterization of Magnetic Nanoparticles and their internalization on Tumor Cell Lines

    Article • February 2019, Institute of Electrical & Electronics Engineers (IEEE)

    Paula Videira

  49. International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up

    Article • Journal of Inherited Metabolic Disease, January 2019, Wiley

    Rita Barone, Paula Videira

  50. Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review

    Article • Orphanet Journal of Rare Diseases, November 2018, Springer Science + Business Media

    Paula Videira

  51. Tools for the Screening of Sarcopenia: A Head-to-Head Comparison by the NOVA SarcoAging Group

    Article • Archives of Physical Medicine and Rehabilitation, October 2018, Elsevier

    Paula Videira

  52. A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, September 2018, Elsevier

    Paula Videira

  53. Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells

    Article • Blood Cancer Journal, August 2018, Springer Science + Business Media

    Prof. Dr. Jens Pietzsch, Paula Videira

  54. Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids

    Article • Scientific Reports, August 2018, Springer Science + Business Media

    Professor Luis Lima, Paula Videira

  55. Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration

    Article • The Journal of Immunology, August 2018, The American Association of Immunologists

    Paula Videira

  56. Halilectin-3, a Lectin from the Marine Sponge Haliclona caerulea, Induces Apoptosis and Autophagy in Human Breast Cancer MCF7 Cells Through Caspase-9 Pathway and LC3-II Protein Expression

    Article • Anti-Cancer Agents in Medicinal Chemistry, July 2018, Bentham Science Publishers

    Professor Alexandra R Fernandes, zélia Silva, Paula Videira

  57. Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease

    Article • Frontiers in Neuroscience, June 2018, Frontiers

    Paula Videira

  58. Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue

    Article • BMC Cancer, May 2018, Springer Science + Business Media

    Paula Videira

  59. CDG Therapies: From Bench to Bedside

    Article • International Journal of Molecular Sciences, April 2018, MDPI AG

    Paula Videira

  60. Reconstruction of a 10-mm-long median nerve gap in an ischemic environment using autologous conduits with different patterns of blood supply: A comparative study in the rat

    Article • PLOS One, April 2018, PLOS

    Paula Videira

  61. Antibacterial activity of a new lectin isolated from the marine sponge Chondrilla caribensis

    Article • International Journal of Biological Macromolecules, April 2018, Elsevier

    Paula Videira

  62. Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer

    Article • Talanta, April 2018, Elsevier

    Paula Videira

  63. Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1

    Article • BMC Cancer, February 2018, Springer Science + Business Media

    Paula Videira

  64. Correction: Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases

    Article • PLOS One, February 2018, PLOS

    Paula Videira

  65. Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods

    Article • Biological Procedures Online, February 2018, Springer Science + Business Media

    Paula Videira

  66. Structural characterization of two isolectins from the marine red alga Solieria filiformis (Kützing) P.W. Gabrielson and their anticancer effect on MCF-7 breast cancer cells

    Article • International Journal of Biological Macromolecules, February 2018, Elsevier

    Paula Videira

  67. E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy

    Article • Frontiers in Immunology, January 2018, Frontiers

    Paula Videira

  68. Green synthesis and structural characterization of completely decomposed granite (CDG) based geopolymer

    Article • January 2018, American Institute of Physics

    Paula Videira

  69. An Electronic Questionnaire for Liver Assessment in Congenital Disorders of Glycosylation (LeQCDG): A Patient-Centered Study

    Article • JIMD Reports, January 2018, Springer Science + Business Media

    Paula Videira

  70. Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation and ERK1/2 and p38 MAPK activation

    Article • Molecular Oncology, December 2017, Wiley

    Paula Videira

  71. Reconstruction of a long defect of the ulnar artery and nerve with an arterialized neurovenous free flap in a teenager: A case report and literature review

    Article • Microsurgery, November 2017, Wiley

    Diogo Casal, Paula Videira

  72. Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation

    Article • BMC Health Services Research, September 2017, Springer Science + Business Media

    Paula Videira

  73. Blood Supply to the Integument of the Abdomen of the Rat: A Surgical Perspective

    Article • Plastic and Reconstructive Surgery Global Open, September 2017, Wolters Kluwer Health

    Paula Videira

  74. Optimization of an Arterialized Venous Fasciocutaneous Flap in the Abdomen of the Rat

    Article • Plastic and Reconstructive Surgery Global Open, August 2017, Wolters Kluwer Health

    Paula Videira

  75. Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases

    Article • PLOS One, May 2017, PLOS

    Paula Videira

  76. Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology

    Article • The Journal of Immunology, May 2017, The American Association of Immunologists

    Paula Videira

  77. Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage

    Article • Oncotarget, April 2017, Impact Journals, LLC

    Paula Videira

  78. Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature

    Article • Journal of Inherited Metabolic Disease, January 2017, Wiley

    Paula Videira

  79. A Model of Free Tissue Transfer: The Rat Epigastric Free Flap

    Article • Journal of Visualized Experiments, January 2017, MyJove Corporation

    Paula Videira

  80. Glycosyltransferase inhibitors: a promising strategy to pave a path from laboratory to therapy

    Article • January 2017, Royal Society of Chemistry

    Dr Ravneet K Grewal, Paula Videira

  81. Bioactivity gradients of cytoprotective and anticancer catechins in skin: Simulation studies for the design of controlled release systems

    Article • January 2017, Institute of Electrical & Electronics Engineers (IEEE)

    Paula Videira

  82. Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions

    Article • Medical Microbiology and Immunology, December 2016, Springer Science + Business Media

    Paula Videira

  83. Vaccine and Antibody Therapy Against Thomsen- Friedenreich Tumor-Associated Carbohydrate Antigens

    Article • December 2016, Bentham Science Publishers

    Paula Videira

  84. Systematic Review and Meta-Analysis of Unconventional Perfusion Flaps in Clinical Practice

    Article • Plastic & Reconstructive Surgery, August 2016, Wolters Kluwer Health

    Paula Videira

  85. Immunological aspects of congenital disorders of glycosylation (CDG): a review

    Article • Journal of Inherited Metabolic Disease, July 2016, Wiley

    Paula Videira

  86. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses

    Article • Oncotarget, July 2016, Impact Journals, LLC

    Professor Alexandra R Fernandes, Paula Videira

  87. In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex

    Article • Molecular BioSystems, January 2016, Royal Society of Chemistry

    Dr Pedro Viana Baptista, Professor M. Fátima C. Guedes da Silva, Professor Alexandra R Fernandes, Paula Videira

  88. Immature myeloid cells and tolerogenic cytokine profile in lung adenocarcinoma metastatic lymph nodes assessed by endobronchial ultrasound

    Article • Tumor Biology, August 2015, Springer Science + Business Media

    Paula Videira

  89. Challenges in Antibody Development against Tn and Sialyl-Tn Antigens

    Article • Biomolecules, August 2015, MDPI AG

    Paula Videira

  90. Protein disulfide isomerases: Impact of thapsigargin treatment on their expression in melanoma cell lines

    Article • International Journal of Biological Macromolecules, August 2015, Elsevier

    Paula Videira

  91. Characterization of antiproliferative potential and biological targets of a copper compound containing 4′-phenyl terpyridine

    Article • JBIC Journal of Biological Inorganic Chemistry, June 2015, Springer Science + Business Media

    Dr Pedro Viana Baptista, Dr João C Lima, Professor Alexandra R Fernandes, Paula Videira

  92. Sweet side of bladder cancer

    Article • World Journal of Clinical Urology, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Paula Videira

  93. Characterization of the antiproliferative potential and biological targets of a trans ketoimine platinum complex

    Article • Inorganica Chimica Acta, November 2014, Elsevier

    Professor Alexandra R Fernandes, Paula Videira

  94. Abstract 3163: Transendothelial migration of uveal melanoma cells

    Article • Cancer Research, October 2014, American Association for Cancer Research (AACR)

    Paula Videira

  95. Meeting report on EMBO Workshop: Glycobiology and glycochemistry, applications to human health and disease

    Article • Glycobiology, July 2014, Oxford University Press (OUP)

    Paula Videira

  96. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells

    Article • Molecular Oncology, March 2014, Wiley

    Paula Videira

  97. Intravital microscopy technique to study parasite dynamics in the labyrinth layer of the mouse placenta

    Article • Parasitology International, February 2014, Elsevier

    Dr. Claudio Romero Farias Marinho, Paula Videira

  98. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer

    Article • Urologic Oncology Seminars and Original Investigations, January 2014, Elsevier

    Professor Luis Lima, Paula Videira

  99. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines

    Article • European Journal of Medicinal Chemistry, December 2013, Elsevier

    Ana Francisco, Rafael Nunes, Paula Videira

  100. Cytokeratin 19, Carcinoembryonic Antigen, and Epithelial Cell Adhesion Molecule Detect Lung Cancer Lymph Node Metastasis in Endobronchial Ultrasound-Guided Transbronchial Aspiration Samples

    Article • Clinical Lung Cancer, November 2013, Elsevier

    Paula Videira

  101. Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy

    Article • British Journal of Cancer, September 2013, Springer Science + Business Media

    Professor Luis Lima, Paula Videira

  102. Overexpression of tumour-ssociated carbohydrate antigen sialyl-Tn in advanced bladder tumours

    Article • Molecular Oncology, March 2013, Wiley

    Professor Luis Lima, Paula Videira

  103. Diagnostic value of endobronchial and endoscopic ultrasound-guided fine needle aspiration for accessible lung cancer lesions after non-diagnostic conventional techniques: a prospective study

    Article • BMC Cancer, March 2013, Springer Science + Business Media

    Paula Videira

  104. The phagocytic capacity and immunological potency of human dendritic cells is improved by α2,6‐sialic acid deficiency

    Article • Immunology, February 2013, Wiley

    Paula Videira

  105. Biological targets of new metal compounds

    Article • Drug Metabolism and Drug Interactions, January 2013, De Gruyter

    Professor M. Fátima C. Guedes da Silva, Professor Alexandra R Fernandes, Professor Luísa Margarida Martins, Paula Videira

  106. Dendritic Cells: A Spot on Sialic Acid

    Article • Frontiers in Immunology, January 2013, Frontiers

    Paula Videira

  107. Sialyl-Tn in Cancer: (How) Did We Miss the Target?

    Article • Biomolecules, October 2012, MDPI AG

    Paula Videira

  108. Postprandial Insulin Resistance in Zucker Diabetic Fatty Rats is Associated with Parasympathetic‐Nitric Oxide Axis Deficiencies

    Article • Journal of Neuroendocrinology, September 2012, Wiley

    Paula Videira

  109. Bladder cancer–glycosylation insights

    Article • January 2012, Royal Society of Chemistry

    Paula Videira

  110. Sialylation and dendritic cells: bridging innate and adaptive immune responses

    Article • December 2011, Royal Society of Chemistry

    Paula Videira

  111. Understanding Postprandial Glucose Clearance by Peripheral Organs: The Role of the Hepatic Parasympathetic System

    Article • Journal of Neuroendocrinology, November 2011, Wiley

    Paula Videira

  112. The Role of Sugars in Dendritic Cell Trafficking

    Article • Annals of Biomedical Engineering, November 2011, Springer Science + Business Media

    Paula Videira

  113. Sialyl Lewisx-dependent binding of human monocyte-derived dendritic cells to selectins

    Article • Biochemical and Biophysical Research Communications, June 2011, Elsevier

    Paula Videira

  114. Screening of congenital cytomegalovirus infection by real-time PCR in urine pools

    Article • European Journal of Pediatrics, May 2011, Springer Science + Business Media

    Paula Videira

  115. Abstract 377: Multifunctional magnetic nanoparticles for theranostic applications

    Article • Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Paula Videira

  116. IL-4 and TNF-α Polymorphisms Are Associated with Risk of Multiple Superficial Tumors or Carcinoma in situ Development

    Article • Urologia Internationalis, January 2011, Karger Publishers

    Professor Luis Lima, Paula Videira

  117. Effects of Bevacizumab on Autocrine VEGF Stimulation in Bladder Cancer Cell Lines

    Article • Urologia Internationalis, January 2011, Karger Publishers

    Paula Videira

  118. Human dendritic cells contain cell surface sialyltransferase activity

    Article • Immunology Letters, June 2010, Elsevier

    Paula Videira

  119. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines

    Article • BMC Cancer, October 2009, Springer Science + Business Media

    Paula Videira

  120. Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines

    Article • Urology, October 2009, Elsevier

    Paula Videira

  121. Effect of sialic acid loss on dendritic cell maturation

    Article • Immunology, August 2009, Wiley

    Paula Videira

  122. Regulatory cells, cytokine pattern and clinical risk factors for asthma in infants and young children with recurrent wheeze

    Article • Clinical & Experimental Allergy, July 2009, Wiley

    Paula Videira

  123. Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis

    Article • Glycoconjugate Journal, December 2007, Springer Science + Business Media

    Paula Videira

  124. Os factores genéticos da asma

    Article • Revista Portuguesa de Pneumologia (English Edition), November 2006, Elsevier

    Paula Videira

  125. Sa.123. Sialylation on Human Monocyte-Derived Dendritic Cells

    Article • Clinical Immunology, January 2006, Elsevier

    Paula Videira

  126. Functional and Topological Analysis of the Burkholderia cenocepacia Priming Glucosyltransferase BceB, Involved in the Biosynthesis of the Cepacian Exopolysaccharide

    Article • Journal of Bacteriology, July 2005, ASM Journals

    Paula Videira

  127. Studies on the Involvement of the Exopolysaccharide Produced by Cystic Fibrosis-Associated Isolates of the Burkholderia cepacia Complex in Biofilm Formation and in Persistence of Respiratory Infections

    Article • Journal of Clinical Microbiology, July 2004, ASM Journals

    Dr Leonilde M Moreira, Jorge Leitão, Paula Videira

  128. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide

    Article • Biochemical and Biophysical Research Communications, December 2003, Elsevier

    Dr Leonilde M Moreira, Jorge Leitão, Paula Videira

  129. Sphingomonas paucimobilis beta-glucosidase Bgl1: a member of a new bacterial subfamily in glycoside hydrolase family 1

    Article • Biochemical Journal, March 2003, Portland Press Ltd.

    Paula Videira

  130. Cloning and sequence analysis of the ces10 gene encoding a Sphingomonas paucimobilis esterase

    Article • Applied Microbiology and Biotechnology, February 2003, Springer Science + Business Media

    Paula Videira

  131. Gellan gum biosynthesis in Sphingomonas paucimobilis ATCC 31461: Genes, enzymes and exopolysaccharide production engineering

    Article • Journal of Industrial Microbiology & Biotechnology, October 2002, Springer Science + Business Media

    Dr Leonilde M Moreira, Paula Videira

  132. Biochemical characterization of the β-1,4-glucuronosyltransferase GelK in the gellan gum-producing strain Sphingomonas paucimobilis A.T.C.C. 31461

    Article • Biochemical Journal, September 2001, Portland Press Ltd.

    Paula Videira

  133. Identification of the pgmG Gene, Encoding a Bifunctional Protein with Phosphoglucomutase and Phosphomannomutase Activities, in the Gellan Gum-Producing Strain Sphingomonas paucimobilis ATCC 31461

    Article • Applied and Environmental Microbiology, May 2000, ASM Journals

    Paula Videira